Skip to search formSkip to main contentSkip to account menu

MPL NP_005364.1:p.W515K

Known as: c-MPL p.Trp515Lys, TPO-R W515L, Proto-Oncogene c-Mpl Trp515Lys 
A change in the amino acid residue at position 515 in the thrombopoietin receptor protein where tryptophan has been replaced by lysine.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Amac: Bu calismanin amaci, bcr-abl negatif kronik miyeloproliferatif hastalik tanisi alan hastalarin tani aninda JAK2 V617F… 
2018
2018
OBJECTIVE To analyze the mutation rate and clinical characteristics of CALR, MPL W515K and JAK2 V617F genes in patients with… 
2018
2018
Myeloproliferative neoplasms (MPNs) driver mutations are usually found in JAK2, MPL, and CALR genes; however, 10%‐15% of cases… 
Review
2017
Review
2017
Aplastic anemia which was once considered as rare and invariably fatal disease. Over the years the understanding of its… 
2015
2015
OBJECTIVE To explore the prevalence of CARL gene mutations and the mutation types in patients with essential thrombocythemia (ET… 
Review
2014
Review
2014
Essential thrombocythaemia (ET) is a myeloproliferative neoplasm characterized by a sustained elevation of the platelet count and… 
2009
2009
Acquired mutations in the juxtamembrane region of MPL (W515L or W515K), the receptor for thrombopoietin, have been reported in…